Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
PTX Announcements
PTX secures EU Authorisation to…
PTX
PRESCIENT THERAPEUTICS LIMITED
Market sensitive
PTX secures EU Authorisation to commence PTX-100 Trial
Date and time
15 December 2025 at 8:10 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
PTX announcement history
Recent PTX announcements
Appendix 4G and Corporate Governance Statement
Appendix 4E and 2026 Annual Report
June 2026 Quarterly Update and Appendix 4C
Notification of cessation of securities - PTX
PTX Dr Rosalind Wilson appointed as Chief Medical Officer
Response to ASX Price Query